Updated Guide,1 to less than 1.5 kcal/mL peptide based

Peptide-based enteral feeds represent a specialized area of nutritional support designed to optimize digestion and absorption, particularly for individuals experiencing gastrointestinal distress or malabsorption. These formulations differ significantly from standard polymeric formulas by utilizing proteins that have been pre-digested into smaller components. This article delves into the science behind peptide-based enteral nutrition, its applications, benefits, and considerations for its use, drawing on current research and clinical understanding.

At its core, enteral nutrition involves providing nutrients directly into the gastrointestinal tract. When standard formulas, which contain intact proteins, lead to feeding intolerance (EFI), peptide-based enteral formulas (PBFs) often become the preferred choice. This is because, in PBFs, proteins have been hydrolyzed, meaning they are broken down into smaller peptides, and in some cases, even free amino acids. This predigestion significantly eases the burden on the digestive system, making them designed to be easier on the digestive system and more tolerable. Research has indicated that peptide-based enteral diets are associated with better protein responses and a reduction in gastrointestinal symptoms like diarrhea.

The process of hydrolysis means that the proteins in these formulas are broken down into smaller molecules, specifically dipeptides and tripeptides, and sometimes even shorter peptides. This is a key distinction from standard polymeric formulas that rely on the body's own enzymes to break down intact proteins. The result is that peptide-based formulas are enteral nutrition solutions that are more readily absorbed. Studies have highlighted that predigested, peptide-based enteral formulas are commonly used to promote GI tolerance in critically ill patients and that they contain proteins that have been hydrolyzed to produce peptides of varying lengths.

Who Benefits from Peptide-Based Enteral Feeds?

The primary indication for peptide-based enteral feeds is feeding intolerance. This can manifest in various ways, including nausea, vomiting, abdominal distension, cramping, and diarrhea, especially in patients with compromised gastrointestinal function. Individuals who may benefit include:

* Critically ill patients: Those in intensive care units often have impaired digestion and absorption due to their underlying condition and medical treatments.

* Patients with malabsorption syndromes: Conditions like short-bowel syndrome, inflammatory bowel disease (IBD), or pancreatic insufficiency can hinder the body's ability to digest and absorb nutrients from intact proteins. As noted, PBFs may be helpful with very specific patients, such as those with malabsorption or pancreatic dysfunction.

* Patients with delayed gastric emptying: When the stomach empties its contents slowly, it can lead to discomfort and poor tolerance of standard feeds.

* Post-surgical patients: Certain surgeries, particularly those involving the gastrointestinal tract, can temporarily impair digestive capabilities.

* Children with gastrointestinal disorders: Specialized formulas like Nutrini Peptisorb is a nutritionally complete 1kcal/ml peptide based tube feed, designed for children aged 1-6 years or 8-20kg in body weight, are available for pediatric populations. A whey peptide-based enteral formula has also been utilized in children with GI disorders.

The benefits extend beyond just improved tolerance. Research suggests that Use of PBD improves EFI and can lead to better nutritional status and clinical outcomes. For instance, studies have explored the Use of a specialized peptide-based enteral formula containing medium-chain triglycerides for enteral tube feeding in children with cerebral palsy and previous GI issues.

Types and Formulations of Peptide-Based Enteral Feeds

The market offers a variety of peptide-based formulas, catering to different caloric and nutritional needs. These can range from standard caloric density (e.g., 1 kcal/mL) to higher caloric densities (e.g., 1.5 kcal/mL) for patients requiring increased energy intake. Examples include:

* VITAL PEPTIDE 1.5 CAL: This is a nutritionally complete, peptide-based formula designed for individuals 14 years and older with malabsorption.

* PIVOT 1.5 CAL is peptide-based complete, balanced therapeutic nutrition: This formulation is suitable for both short-term and long-term tube feeding for metabolically stressed individuals, including those recovering from surgery, trauma, or burns.

* Compleat® Peptide Tube Feeding Formulas: These offer plant-based, real food ingredient formulas with hydrolyzed pea protein, designed for individuals with intolerances.

* Peptamen® Range: This line of products is specifically designed for adults with conditions such as malabsorption, diarrhea, delayed gastric emptying, and short-bowel syndrome.

* Nourish Peptide: This is highlighted as the first organic, whole food, plant-based peptide feeding tube formula and meal replacement optimized for children.

These formulas are often referred to as semi-elemental or elemental diets, depending on the degree of protein hydrolysis. Peptamen is a well-known brand in this category. The availability of 1 to less than 1.5 kcal/mL peptide based options provides flexibility in meeting individual patient requirements.

Efficacy and Clinical Evidence

The evidence